Home
→
Browsing by Author

Browsing by Author "Golemis E.A."

Now showing items 1-6 of 6

Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer

Gabitova-Cornell L.; Surumbayeva A.; Peri S.; Franco-Barraza J.; Restifo D.; Weitz N.; Ogier C.; Goldman A.R.; Hartman T.R.; Francescone R.; Tan Y.; Nicolas E.; Shah N.; Handorf E.A.; Cai K.Q.; O'Reilly A.M.; Sloma I.; Chiaverelli R.; Moffitt R.A.; Khazak V.; Fang C.Y.; Golemis E.A.; Cukierman E.; Astsaturov I. (2020)

© 2020 Elsevier Inc. Oncogenic transformation alters lipid metabolism to sustain tumor growth. We define a mechanism by which cholesterol metabolism controls the development and differentiation of pancreatic ductal ...
Identification of the KRIT1 protein by LexA-based yeast two-hybrid system

Serebriiskii I.G.; Elmekawy M.; Golemis E.A. (2020)

© Springer Science+Business Media, LLC, part of Springer Nature 2020. Cerebral cavernous malformation (CCM) is a vascular malformation of the central nervous system that is associated with leaky capillaries, and a ...
Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Kiseleva A.A.; Golemis E.A. (2020)
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Makhov P.; Bychkov I.; Faezov B.; Deneka A.; Kudinov A.; Nicolas E.; Brebion R.; Avril E.; Cai K.Q.; Kharin L.V.; Voloshin M.; Frantsiyants E.; Karnaukhov N.; Kit O.I.; Topchu I.; Fazliyeva R.; Nikonova A.S.; Serebriiskii I.G.; Borghaei H.; Edelman M.; Dulaimi E.; Golemis E.A.; Boumber Y. (2021)

Non-small cell lung cancer (NSCLC) has limited treatment options. Expression of the RNA-binding protein (RBP) Musashi-2 (MSI2) is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon progression, and ...
Nedd9 restrains autophagy to limit growth of early stage non-small cell lung cancer

Deneka A.Y.; Kopp M.C.; Nikonova A.S.; Gaponova A.V.; Kiseleva A.A.; Hensley H.H.; Flieder D.B.; Serebriiskii I.G.; Golemis E.A. (2021)

Non-small cell lung cancer (NSCLC) is the most common cancer worldwide. With overall 5-year survival estimated at <17%, it is critical to identify factors that regulate NSCLC disease prognosis. NSCLC is commonly driven by ...
Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer

Hartman T.R.; Demidova E.V.; Lesh R.W.; Hoang L.; Richardson M.; Forman A.; Kessler L.; Speare V.; Golemis E.A.; Hall M.J.; Daly M.B.; Arora S. (2020)

© 2020, The Author(s). Pathogenic variants (PVs) in multiple genes are known to increase the risk of early-onset renal cancer (eoRC). However, many eoRC patients lack PVs in RC-specific genes; thus, their genetic risk ...

Now showing items 1-6 of 6

Search DSpace

Advanced Search

Browse

All of Kazan Federal University Digital Repository

Browsing by Author "Golemis E.A."

Browsing by Author "Golemis E.A."

Search DSpace

Browse

All of Kazan Federal University Digital Repository

My Account